Dr. Foulds is the Director of the Tobacco Dependence Program at the School of Public Health at the University of Medicine and Dentistry of New Jersey. He previously trained as a Clinical Psychologist in Scotland, and then did research and clinical work on tobacco dependence in London for over 10 years. He has been a consultant on tobacco dependence to the World Health Organization and the Hungarian Ministry of Health, and before coming to New Jersey was Director of Research for the smoking cessation charity Quit.

Christopher Haines is a Clinical Instructor in the Division of Geriatrics, Department of Family Medicine at Thomas Jefferson University Hospital where he is the clinical director of the Family Medicine inpatient service. Dr. Haines received his B.A. in European History from the University of Pennsylvania, his M.A. in European Intellectual History from Villanova University, and his M.D. from Jefferson Medical College.

Dr. Leone is an Associate Professor of Medicine at Jefferson Medical College and Director, Center for Tobacco Research and Treatment at Thomas Jefferson University Hospital. Dr. Leone's research Interests include tobacco use is the behavioral manifestation of one of the most complex neurophysiologic disorders known to science. Despite the well known health effects of smoking, millions of Americans continue to use this deadly product, and physicians continue to feel powerless to effect change. The Center's research activities focus on questions central to improving the care of smokers, including the genetics of nicotine addiction, molecular epidemiology, clinical treatment trials, policy research, communication research, and development of education / training paradigms for healthcare providers.

Kathleen Oare is the clinical nurse specialist for the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases. She is a graduate of the St. Francis Hospital School of Nursing and received her bachelor's and master's degrees in nursing from the University of Pittsburgh. Ms. Lindell's nursing focus has been on clinical care, and she was a clinical nurse specialist in the University of Pennsylvania Lung Center for 10 years. She has participated in research projects about asthma and smoking cessation; published articles, book chapters, and Web articles on a number of lung-related topics; and presented at national meetings. Currently she is on the Strategic Advisory Board for the Coalition for Pulmonary Fibrosis.

Dr. Nash is The Dr. Raymond C. and Doris N. Grandon Professor and Chairman of the Department of Health Policy at Jefferson Medical College of Thomas Jefferson University in Philadelphia. Jefferson is one of a handful of medical schools in the nation with an endowed professorship in health policy. Dr. Nash, a board certified internist, founded the original Office of Health Policy in 1990. From 1996 to 2003, he served as the first Associate Dean for Health Policy at Jefferson Medical College. In 2004, he was named Co-director of the Masters Program in Public Health at Jefferson and was named as a finalist in the 15th Annual Discover Awards for Innovation in Public Health by Discover magazine.

Internationally recognized for his work in outcomes management, medical staff development and quality-of-care improvement, his publications have appeared in more than 100 articles in major journals and in thirteen edited books, including A Systems Approach to Disease Management by Jossey-Bass Publishers and Connecting with the New Healthcare Consumer by Aspen Publishers. In 1995, he was awarded the Latiolais ("Lay-shee-o-lay") Prize by the Academy of Managed Care Pharmacy for his leadership in disease management and pharmacoeconomics. He also received the Philadelphia Business Journal Healthcare Heroes Award in October 1997 and was named an honorary distinguished fellow of the American College of Physician Executives in 1998.

Repeatedly named by Modern Healthcare to the top 100 most powerful persons in healthcare list, his national activities include appointment to the JCAHO Advisory Committee on Performance Measurement, the CIGNA Privacy Board, and membership on the Board of Directors of the Disease Management Association of America (DMAA) - three key national groups focusing on quality measurement and improvement. He continues as one of the principal faculty members for quality of care issues of the American College of Physician Executives in Tampa, Florida, and the developer of the ACPE Capstone Course on Quality. Dr. Nash is on the National Advisory Committee for the Robert Wood Johnson Foundation Partnerships in Quality Education program, bringing together managed care organizations and leading academic medical centers. Finally, he is a member of the Board of Trustees of Catholic Healthcare Partners in Cincinnati, Ohio - one of the nation's largest integrated delivery systems and chairs the Board Committee on Quality.

Dr. Nash is a consultant to organizations in both the public and private sectors including the Technical Advisory Group of the Pennsylvania Health Care Cost Containment Council (a group he has chaired for the last six years), and numerous corporations within the pharmaceutical industry. He is on the board of directors and advisory board of multiple healthcare companies. From 1984 to 1989, he was Deputy Editor, Annals of Internal Medicine, at the American College of Physicians. Currently, he is Editor-in-Chief of P&T, Disease Management, Biotechnology Healthcare and the American Journal of Medical Quality.

Dr. Nash received his BA in economics (Phi Beta Kappa) from Vassar College, Poughkeepsie, New York; his MD from the University of Rochester School of Medicine and Dentistry; and his MBA in Health Administration (with honors) from the Wharton School at the University of Pennsylvania. While at Penn, he was a former Robert Wood Johnson Foundation Clinical Scholar and Medical Director of a nine physician faculty group practice in general internal medicine.

Dr. Schnoll is an Associate Member, Population Science Division, Fox Chase Cancer Center. His research interests include Deaths attributable to tobacco use outnumber those due to AIDS, alcohol, car accidents, homicide, illicit drug use, and suicide combined. Current research focuses on the design, evaluation, and dissemination of biobehavioral interventions that can help prevent the development of tobacco-related cancers via tobacco use cessation and to explore how behavioral science can be incorporated into lung screening practice in order to maximize the benefits of emergent lung screening technologies. In particular, our current studies focus on the evaluation of treatments for nicotine addiction - both behavioral and pharmacologic - among cancer patients, including the examination of the ways in which patient's psychological profile mitigates responsiveness to anti-depressant treatment for nicotine addiction. In addition, we are examining the effectiveness of two forms of behavioral treatment for nicotine addiction among low-income pregnant women who smoke and assessing the degree to which certain genetic characteristics influence responsiveness to these treatments. Finally, our current research is also focused on understanding the ways in which lung cancer screening programs can be implemented so that their benefits in terms of the prevention of tobacco-related cancers are maximized. Our future research agenda includes the development of tobacco control infrastructure and service in the Russian Federation, the expansion of nicotine addiction treatments to cancer patient's relatives who smoke, and the development of web-based smoking cessation treatment training programs for physicians.

Dr. Weibel is a Clinical Assistant Professor of Medicine, Medical Director, Pulmonary Function Laboratory and Respiratory Care and Associate Director, Center for Tobacco Research and Treatment at Thomas Jefferson Univeristy Hospital. Major Research Interests Exercise physiology, nosocomial pneumonia, interstitial lung diseases, sarcoid, smoking cessation, COPD, and lung cancer.Dr. Weible received her B.A. in Biology/Chemistry University of Pennsylvania, Philadelphia, PA and her M.D. Medicine from University of Pittsburgh.

Dr. Wender is Alumni Professor and Chairman of the Department of Family Medicine at Thomas Jefferson University in Philadelphia. A graduate of Princeton University and University of Pennsylvania School of Medicine, Dr. Wender, directed the Family Practice residency program at Thomas Jefferson for 10 years and became Vice Chairman of the Department in 1995. He was appointed Chair of the Department in August of 2002. In addition to being a practicing family doctor, Rich's major area of academic focus has been cancer prevention and screening. He was the editor of the American Cancer Society Primary Care Physicians Newsletter for 10 years and is now on the Editorial Advisory Board of CA - a journal for clinicians, and for Patient Care. Dr. Wender has served as President of the Pennsylvania Division of the American Cancer Society and is now on the ACS national Board of Directors. He is co-chair of the Clinician Workgroup of the National Colorectal Roundtable and worked with the CDC to develop a national training program for clinicians about colorectal cancer prevention and screening. Dr. Wender was co-chair of the ACS Prostate Cancer Screening Guidelines Review Group in 2000.

Dr. Witt is a Board Certification Family Practice Physician at Thomas Jefferson University Hospital and an Assistant Professor at Jefferson Medical College Dr. Witt graduated from Hahnemann University School of Medicine.